Replies to post #608981 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

He's not the only one showing this confidence!

...some are viewing us as leaders in the world of now coming up with novel combinations to add – to turn – what previously were called cold tumors because they didn’t respond to immunotherapies, into tumors that were hot and highly responsive.

^^ George D. Yancopoulos, MD, PhD, Co-Founder, President and Chief Scientific Officer, Regeneron

Some fun speculation:

(Fun speculation on potential partner/licensor to handle the commercialization of #DCVax-L)$REGN sounds like they are reading from $NWBO's website at their June 9th, 2023 ASM 😉

Leonard S. Schleifer, MD, PhD, Co-founder, President and Chief Executive Officer @Regeneron :…

— hoffmann6383 (@hoffmann6383) July 12, 2023